A Randomized Phase II Study of Intrabucally Administered Electromagnetic Fields versus Placebo for Patients with Child-Pugh A or B Advanced Hepatocellular Carcinoma

The primary goal of this study is to gather efficacy data concerning overall survival with electromagnetic fields when compared to a placebo amplitude-modulated radiofrequency electromagnetic field device in subjects who have failed or are intolerant to at least two previous systemic therapies.